Astonishing Labs: Pioneering the Future of Biotech

Biotechnology has seen significant advancements over recent years, yet many groundbreaking research ideas remain unexploited due to lack of support. Astonishing Labs is transforming this landscape by partnering with university scientists to bring their innovative research into the commercial domain. The company focuses on developing platform companies based on revolutionary scientific discoveries, aiming to address large-scale healthcare challenges.

A Founding Team with Visionary Expertise

Developing successful biotech startups requires a unique blend of scientific insight, entrepreneurial drive, and regulatory expertise. The team at Astonishing Labs embodies these qualities, driven by their passion to push the boundaries of conventional scientific thinking and create therapies that can significantly impact human health.

The company was co-founded by Dr. Michael Levin, Jess Mah, and Tom Cirrito.

Dr. Michael Levin, a distinguished scientist in developmental and regenerative biology, serves as the scientific co-founder. His work at Tufts University and the Wyss Institute has paved the way for groundbreaking discoveries in bioelectricity and cellular communication.

Jess Mah, a successful entrepreneur featured on Forbes 30 Under 30 and Inc. 30 Under 30 lists, brings a wealth of experience in tech and business innovation.

Tom Cirrito, a seasoned inventor and biotech entrepreneur, currently serves as the Managing Partner. His extensive background includes founding multiple biotech companies and leading them to success.

Leveraging Synthetic Biology for Healthcare Solutions

Astonishing Labs is dedicated to challenging established scientific dogma and developing transformative therapies. By using synthetic biology and other advanced technologies, they aim to address multiple diseases and create solutions that can benefit large patient populations. Their approach involves:

Comprehensive Support: Providing the necessary resources and guidance to navigate the complex journey from research to commercial success.

Partnership with Scientists: Collaborating with leading researchers to translate early-stage scientific discoveries into platform companies.

Innovative Research: Focusing on cutting-edge areas such as cellular electrical signaling for cancer treatment and organ regeneration.

Commitment to Revolutionary Biotech Solutions

Astonishing Labs is driven by a mission to revolutionize modern medicine. By investing in and nurturing early-stage research, the company aims to create groundbreaking biotech solutions that can significantly improve human health and well-being.

Join the Revolution

At Base Ventures we recognize the transformative potential of Astonishing Labs’s technology and share its vision of bridging research and the commercial domain.  We are thrilled to announce our seed stage investment in Astonishing Labs, alongside firms such as Audrey Capital. We are eager to see more users benefit from Astonishing Labs’s ability to bridge research and the commercial domain.

“At Astonishing Labs, we believe in the power of science to change the world. By partnering with top university scientists and leveraging advanced technologies, we are creating platform companies that address the most pressing healthcare challenges of our time. Join us in our mission to revolutionize modern medicine and make a lasting impact on human health.”